Submission Details
| 510(k) Number | K133411 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 07, 2013 |
| Decision Date | December 05, 2013 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K133411 is an FDA 510(k) clearance for the ALERE BINAXNOW INFLUENZA A & B CARD, a Antigens, Cf (including Cf Control), Influenza Virus A, B, C (Class I — General Controls, product code GNX), submitted by Alere Scarborough, Inc D/B/A Binax, Inc. (Scarborough, US). The FDA issued a Cleared decision on December 5, 2013, 28 days after receiving the submission on November 7, 2013. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3330.
| 510(k) Number | K133411 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 07, 2013 |
| Decision Date | December 05, 2013 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | GNX — Antigens, Cf (including Cf Control), Influenza Virus A, B, C |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3330 |